<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NULYTELY WITH FLAVOR PACKS- polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chlorideÂ 
			Â </strong><br>Braintree Laboratories, Inc.<br></p></div>
<div id="Highlights" class="Highlights"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1>HIGHLIGHTS OF PRESCRIBING INFORMATION</h1>
<div class="HighlightsDisclaimer">These highlights do not include all the information needed to use NuLYTELY safely and effectively. See full prescribing information for NuLYTELY.<br>NuLYTELY (polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride for oral solution)<br>Initial U.S. Approval: 1991
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>RECENT MAJOR CHANGES</span></h1>
<div><p class="Highlighta">Warnings and Precautions (<a href="#s9">5</a>) 9/2013
 </p></div>
</div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>INDICATIONS AND USAGE</span></h1>
<div><p class="Highlighta">NuLYTELY is a combination of PEG 3350, an osmotic laxative, and electrolytes indicated for cleansing of the colon in preparation for colonoscopy in adults and pediatric patients aged 6 months or greater (<a href="#s2">1</a>)
 </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE AND ADMINISTRATION</span></h1>
<div><ul class="Disc">
<li>NuLYTELY, supplied as a powder, must be reconstituted with water before its use (<a href="#s4">2.1</a>, <a href="#s17">5.8</a>)
</li>
<li>On day prior to colonoscopy, instruct patients to:<ul class="Disc">
<li>Eat a light breakfast or have clear liquids (avoid red and purple liquids) (<a href="#s5">2.2</a>).
</li>
<li>If adding a NuLYTELY flavor pack, pour the contents of flavor powder (i.e., cherry, lemon-lime, orange or pineapple) into container prior to reconstitution (<a href="#s5">2.2</a>).
</li>
<li>Early in the evening prior to colonoscopy, fill container containing NuLYTELY powder with lukewarm water to 4 liter fill line (<a href="#s5">2.2</a>).
</li>
<li>After capping container, shake vigorously several times (<a href="#s5">2.2</a>).
</li>
</ul>
</li>
<li>Instruct patients to consume water or clear liquids during and after bowel preparation up until 2 hours before time of colonoscopy (<a href="#s6">2.3</a>).
</li>
<li>
<span class="Bold">Adults:</span> Drink at a rate of 240 mL (8 oz.) every 10 minutes, until 4 liters are consumed or rectal effluent is clear. For nasogastric tube (NGT), rate is 1.2 to 1.8 liters per hour (<a href="#s6">2.3</a>)
</li>
<li>
<span class="Bold">Pediatric patients (aged 6 months or greater):</span> Drink 25 mL/kg/hour orally or administer by NGT. Continue drinking until watery stool is clear and free of solid matter (<a href="#s6">2.3</a>).
</li>
</ul></div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE FORMS AND STRENGTHS</span></h1>
<div><p class="Highlighta">For oral solution: polyethylene glycol 3350 420 grams, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 grams, sodium chloride 11.2 grams, potassium chloride 1.48 grams, and flavoring ingredients 2 grams; supplied in one 4 liter disposable jug (<a href="#s7">3</a>)
 </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>CONTRAINDICATIONS</span></h1>
<div><ul class="Disc">
<li>Gastrointestinal (GI) obstruction, <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>, or gastric retention (<a href="#s8">4</a>, <a href="#s15">5.6</a>)
</li>
<li><span class="product-label-link" type="condition" conceptid="193242" conceptname="Perforation of intestine">Bowel perforation</span> (<a href="#s8">4</a>, <a href="#s15">5.6</a>)
</li>
<li>Toxic <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span> or toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span> (<a href="#s8">4</a>)
</li>
<li>Known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> or <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to components of NuLYTELY (<a href="#s8">4</a>, <a href="#s28">11</a>)
</li>
</ul></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>WARNINGS AND PRECAUTIONS</span></h1>
<div><ul class="Disc">
<li>Risk of fluid and electrolyte abnormalities, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> and renal impairmentâ€“ assess concurrent medications and consider testing in some patients (<a href="#s10">5.1</a>, <a href="#s11">5.2</a>, <a href="#s12">5.3</a>, <a href="#s13">5.4</a>)
</li>
<li>Patients with renal insufficiencyâ€“ use caution, ensure adequate hydration and consider testing (<a href="#s13">5.4</a>)
</li>
<li>Suspected GI obstruction or perforation â€“ rule out the diagnosis before administration (<a href="#s8">4</a>, <a href="#s15">5.6</a>)
</li>
<li>Patients at risk for <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> â€“ observe during administration (<a href="#s16">5.7</a>)
</li>
<li>Not for direct ingestion â€“ dilute and take with additional water (<a href="#s17">5.8</a>)
</li>
</ul></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>ADVERSE REACTIONS</span></h1>
<div>
<p class="Highlighta">Most common adverse reactions (â‰¥3%) are: <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">abdominal fullness</span> and <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>. <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal cramps</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and anal irritation occur less frequently (<a href="#s18">6</a>)
 </p>
<p class="Highlighta"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Braintree Laboratories, Inc. at 1-800-874-6756 or FDA at 1-800-FDA-1088 or
</span><span class="Bold Italics">www.fda.gov/medwatch.</span> </p>
</div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DRUG INTERACTIONS</span></h1>
<div><ul class="Disc">
<li>Some drugs increase risks due to fluid and electrolyte changes (<a href="#s20">7.1</a>)
</li>
<li>Oral medication taken within 1 hour of start of each dose may not be absorbed properly (<a href="#s21">7.2</a>)
</li>
</ul></div>
<div></div>
<div></div>
<div></div>
</div>
<div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div>
<div></div>
<div></div>
<div></div>
</div>
<div><div></div></div>
<div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<p class="HighlightsSeeReference">See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.</p>
<p class="HighlightsRevision">Revised: 9/2013</p>
</div></td></tr></table></div>
<div id="Index" class="Index"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1 class="Colspan">FULL PRESCRIBING INFORMATION: CONTENTS<a href="#footnote-content" name="footnote-reference-content">*</a>
</h1>
<h1><a href="#section-1" class="toc">1 INDICATIONS AND USAGE
</a></h1>
<h1><a href="#section-2" class="toc">2 DOSAGE AND ADMINISTRATION
</a></h1>
<h2><a href="#section-2.1" class="toc">2.1 Dosage Overview
</a></h2>
<h2><a href="#section-2.2" class="toc">2.2 Administration Instructions Prior to Dosage
</a></h2>
<h2><a href="#section-2.3" class="toc">2.3 Dosage
</a></h2>
<h1><a href="#section-3" class="toc">3 DOSAGE FORMS AND STRENGTHS
</a></h1>
<h1><a href="#section-4" class="toc">4 CONTRAINDICATIONS
</a></h1>
<h1><a href="#section-5" class="toc">5 WARNINGS AND PRECAUTIONS
</a></h1>
<h2><a href="#section-5.1" class="toc"><span class="XmChange"></span>5.1 Serious Fluid and Serum Chemistry Abnormalities
</a></h2>
<h2><a href="#section-5.2" class="toc"><span class="XmChange"></span>5.2 <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Cardiac Arrhythmias</span>
</a></h2>
<h2><a href="#section-5.3" class="toc"><span class="XmChange"></span>5.3 <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span>
</a></h2>
<h2><a href="#section-5.4" class="toc"><span class="XmChange"></span>5.4 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span>
</a></h2>
<h2><a href="#section-5.5" class="toc"><span class="XmChange"></span>5.5 Colonic <span class="product-label-link" type="condition" conceptid="442121" conceptname="Mucosal ulcer">Mucosal Ulcerations</span> and <span class="product-label-link" type="condition" conceptid="4148299" conceptname="Ischemic colitis">Ischemic Colitis</span>
</a></h2>
<h2><a href="#section-5.6" class="toc"><span class="XmChange"></span>5.6 Use in Patients with Significant Gastrointestinal Disease
</a></h2>
<h2><a href="#section-5.7" class="toc"><span class="XmChange"></span>5.7 <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">Aspiration</span>
</a></h2>
<h2><a href="#section-5.8" class="toc"><span class="XmChange"></span>5.8 Not for Direct Ingestion
</a></h2>
<h1><a href="#section-6" class="toc">6 ADVERSE REACTIONS
</a></h1>
<h1><a href="#section-7" class="toc">7 DRUG INTERACTIONS
</a></h1>
<h2><a href="#section-7.1" class="toc">7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities
</a></h2>
<h2><a href="#section-7.2" class="toc">7.2 Potential for Altered Drug Absorption
</a></h2>
<h2><a href="#section-7.3" class="toc">7.3 Stimulant Laxatives
</a></h2>
<h1><a href="#section-8" class="toc">8 USE IN SPECIFIC POPULATIONS
</a></h1>
<h2><a href="#section-8.1" class="toc">8.1 Pregnancy
</a></h2>
<h2><a href="#section-8.2" class="toc">8.3 Nursing Mothers
</a></h2>
<h2><a href="#section-8.3" class="toc">8.4 Pediatric Use
</a></h2>
<h2><a href="#section-8.4" class="toc">8.5 Geriatric Use
</a></h2>
<h1><a href="#section-9" class="toc">11 DESCRIPTION
</a></h1>
<h1><a href="#section-10" class="toc">12 CLINICAL PHARMACOLOGY
</a></h1>
<h2><a href="#section-10.1" class="toc">12.1 Mechanism of Action
</a></h2>
<h2><a href="#section-10.2" class="toc">12.2 Pharmacodynamics
</a></h2>
<h2><a href="#section-10.3" class="toc">12.3 Pharmacokinetics
</a></h2>
<h1><a href="#section-11" class="toc">13 NONCLINICAL TOXICOLOGY
</a></h1>
<h2><a href="#section-11.1" class="toc">13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</a></h2>
<h1><a href="#section-12" class="toc">16 HOW SUPPLIED/STORAGE AND HANDLING
</a></h1>
<h1><a href="#section-13" class="toc">17 PATIENT COUNSELING INFORMATION
</a></h1>
<dl class="Footnote">
<dt><a href="#footnote-reference-content" name="footnote-content">*</a></dt>
<dd>Sections or subsections omitted from the full prescribing information are not listed.</dd>
</dl>
</div></td></tr></table></div>
<div class="Contents">
<h1>FULL PRESCRIBING INFORMATION</h1>
<div class="Section" data-sectionCode="48780-1">
<a name="dcl-dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s2"></a><a name="section-1"></a><p></p>
<h1>1 INDICATIONS AND USAGE
</h1>
<p class="First">NuLYTELY is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater.
</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s3"></a><a name="section-2"></a><p></p>
<h1>2 DOSAGE AND ADMINISTRATION
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s4"></a><a name="section-2.1"></a><p></p>
<h2>2.1 Dosage Overview
</h2>
<p class="First">NuLYTELY, supplied as a powder, must be reconstituted with water before its use; it is not for direct ingestion <span class="Italics">[see Dosage and Administration (<a href="#s5">2.2</a>), Warnings and Precautions (<a href="#s17">5.8</a>)]</span>. The 4 liter reconstituted NuLYTELY solution contains: 420 grams of polyethylene glycol (PEG) 3350, 5.72 grams of sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, 11.2 grams of sodium chloride, and 1.4 grams of potassium chloride. NuLYTELY may be used with or without one of the supplied flavor packs.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s5"></a><a name="section-2.2"></a><p></p>
<h2>2.2 Administration Instructions Prior to Dosage
</h2>
<p class="First">On the day prior to the colonoscopy, instruct patients to:
</p>
<ol class="LittleAlpha">
<li>Take only clear liquids, but avoid red and purple liquids. Patients may consume a light breakfast.
</li>
<li>If adding a NuLYTELY flavor pack, pour the contents of the 2 gram flavor powder (i.e., cherry, lemon-lime, orange or pineapple) into the container prior to reconstitution. No additional flavorings should be added. Discard unused flavor packs. The NuLYTELY flavor packs are for use only in combination with the contents of the accompanying 4 liter container.
</li>
<li>
<span class="Underline">Early in the evening prior to colonoscopy,</span> fill the supplied container containing the NuLYTELY powder (and if applicable, a flavor powder) with lukewarm water (to facilitate dissolution) to the 4 liter fill line. The solution is clear and colorless when reconstituted to a final volume of 4 liters.
</li>
<li>After capping the container, shake vigorously several times to ensure that the ingredients are dissolved. When reconstituted use within 48 hours.
</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s6"></a><a name="section-2.3"></a><p></p>
<h2>2.3 Dosage
</h2>
<p class="First">The following is the recommended dose of reconstituted NuLYTELY solution for adults and pediatric patients &gt; 6 months. Instruct patients they may consume water or clear liquids during the bowel preparation and after completion of the bowel preparation up until 2 hours before the time of the colonoscopy. The solution is more palatable if chilled prior to administration.
</p>
<ul class="Disc">
<li>
<span class="Bold">Adults:</span> Instruct patients to drink a total of up to 4 liters at a rate of 240 mL (8 oz.) every 10 minutes, until 4 liters are consumed or the rectal effluent is clear. Rapid drinking of each portion is preferred to drinking small amounts continuously. For NGT, rate is 20-30 mL per minute (1.2 â€“ 1.8 liters per hour).
</li>
<li>
<span class="Bold">Pediatric Patients &gt; 6 Months:</span> Pediatric patients should drink 25 mL/kg/hour until the stool is watery, clear, and free of solid matter. If pediatric patients are unable to drink the reconstituted NuLYTELY solution, the solution may be given by nasogastric (NGT). NGT administration is at the rate of 25 mL/kg/hour.
</li>
</ul>
<p>The first bowel movements should occur approximately one hour after the start of NuLYTELY administration. Continue drinking until the watery stool is clear and free of solid matter.
</p>
</div>
</div>
<div class="Section" data-sectionCode="43678-2">
<a name="s7"></a><a name="section-3"></a><p></p>
<h1>3 DOSAGE FORMS AND STRENGTHS
</h1>
<p class="First">For oral solution: One 4 liter jug with powder for reconstitution with water.
</p>
<p>Each 4 liter jug contains: polyethylene glycol 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.48 g and flavoring ingredients 2 g. When made up to 4 liters volume with water, the solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 17 mmol/L and potassium 5 mmol/L.
</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s8"></a><a name="section-4"></a><p></p>
<h1>4 CONTRAINDICATIONS
</h1>
<p class="First">NuLYTELY is contraindicated in the following conditions:
</p>
<ul class="Disc">
<li>Gastrointestinal (GI) obstruction, <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>, or gastric retention
</li>
<li><span class="product-label-link" type="condition" conceptid="193242" conceptname="Perforation of intestine">Bowel perforation</span>
</li>
<li>Toxic <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span> or toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span>
</li>
<li>Known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> or <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of NuLYTELY [<span class="Italics">see How Supplied/Storage and Handling (<a href="#s35">16</a>)</span>]
</li>
</ul>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="s9"></a><a name="section-5"></a><p></p>
<h1>5 WARNINGS AND PRECAUTIONS
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s10"></a><a name="section-5.1"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.1 Serious Fluid and Serum Chemistry Abnormalities
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>Advise patients to hydrate adequately before, during, and after the use of NuLYTELY. Use caution in patients with <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> when replacing fluids. If a patient develops significant <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> or signs of <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span> including signs of <span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">orthostatic hypotension</span> after taking NuLYTELY, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN) and treat accordingly. Fluid and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte disturbances</span> can lead to serious adverse events including <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> and <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>. Fluid and electrolyte abnormalities should be corrected before treatment with NuLYTELY.
</p>
<p style="border-left:1px solid;"><span class="XmChange"></span>In addition, use caution when prescribing NuLYTELY for patients who have conditions, or who are using medications, that increase the risk for fluid and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte disturbances</span> or may increase the risk of adverse events of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, and <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> [<span class="Italics">see Drug Interactions</span> (<a href="#s20">7.1</a>)]
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s11"></a><a name="section-5.2"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.2 <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Cardiac Arrhythmias</span>
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>There have been rare reports of serious <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> associated with the use of ionic osmotic laxative products for bowel preparation. Use caution when prescribing NuLYTELY for patients at increased risk of <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> (e.g., patients with a history of prolonged QT, uncontrolled <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, recent <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">myocardial infarction</span>, <span class="product-label-link" type="condition" conceptid="315296" conceptname="Preinfarction syndrome">unstable angina</span>, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, or <span class="product-label-link" type="condition" conceptid="321319" conceptname="Cardiomyopathy">cardiomyopathy</span>). Pre-dose and post-colonoscopy ECGs should be considered in patients at increased risk of serious <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s12"></a><a name="section-5.3"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.3 <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span>
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>There have been reports of generalized tonic-<span class="product-label-link" type="condition" conceptid="4265182" conceptname="Clonic seizure">clonic seizures</span> and/or <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">loss of consciousness</span> associated with use of bowel preparation products in patients with no prior history of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>. The <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> cases were associated with electrolyte abnormalities (e.g., <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>, <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>, <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span>, and <span class="product-label-link" type="condition" conceptid="4098604" conceptname="Hypomagnesemia">hypomagnesemia</span>) and low serum <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span>. The neurologic abnormalities resolved with correction of fluid and electrolyte abnormalities.
</p>
<p style="border-left:1px solid;"><span class="XmChange"></span>Use caution when prescribing NuLYTELY for patients with a history of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> and in patients at increased risk of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>, such as patients taking medications that lower the <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span> threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s13"></a><a name="section-5.4"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.4 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span>
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>Use caution when prescribing NuLYTELY for patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span> or patients taking concomitant medications that may affect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs). Advise these patients of the importance of adequate hydration, and consider performing baseline and postcolonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s14"></a><a name="section-5.5"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.5 Colonic <span class="product-label-link" type="condition" conceptid="442121" conceptname="Mucosal ulcer">Mucosal Ulcerations</span> and <span class="product-label-link" type="condition" conceptid="4148299" conceptname="Ischemic colitis">Ischemic Colitis</span>
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>Administration of osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of <span class="product-label-link" type="condition" conceptid="4148299" conceptname="Ischemic colitis">ischemic colitis</span> requiring hospitalization. Concurrent use of stimulant laxatives and NuLYTELY may increase this risk. The potential for <span class="product-label-link" type="condition" conceptid="442121" conceptname="Mucosal ulcer">mucosal ulcerations</span> resulting from the bowel preparation should be considered when interpreting colonoscopy findings in patients with known or suspect <span class="product-label-link" type="condition" conceptid="4074815" conceptname="Inflammatory bowel disease">inflammatory bowel disease</span> (IBD).
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s15"></a><a name="section-5.6"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.6 Use in Patients with Significant Gastrointestinal Disease
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>If <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span> or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering NuLYTELY. If a patient experiences severe <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> or <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, administration should be slowed or temporarily discontinued until the symptoms abate. If <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span> or perforation is suspected, appropriate studies should be performed to rule out these conditions before administration of NuLYTELY. Use with caution in patients with severe active <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s16"></a><a name="section-5.7"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.7 <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">Aspiration</span>
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>Use with caution in patients with impaired gag reflex, <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">unconscious</span>, or semiconscious patients, and patients prone to <span class="product-label-link" type="condition" conceptid="4301596" conceptname="Regurgitation">regurgitation</span> or <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span>. Such patients should be observed during administration of NuLYTELY, especially if it is administered via nasogastric tube.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s17"></a><a name="section-5.8"></a><p></p>
<h2 style="border-left:1px solid;">
<span class="XmChange"></span>5.8 Not for Direct Ingestion
</h2>
<p class="First" style="border-left:1px solid;"><span class="XmChange"></span>The contents of each jug must be diluted with water to a final volume of 4 liters (4 L) and ingestion of additional water is important to patient tolerance. Direct ingestion of the undissolved powder may increase the risk of <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte disturbances</span>.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s18"></a><a name="section-6"></a><p></p>
<h1>6 ADVERSE REACTIONS
</h1>
<p class="First">The following adverse reactions have been identified during post-approval use of NuLYTELY. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
</p>
<p><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">abdominal fullness</span> and <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span> are the most common adverse reactions (occurred in up to 50% of patients) to administration of NuLYTELY. <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal cramps</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and anal irritation occur less frequently. These adverse reactions are transient and usually subside rapidly. Isolated cases of <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">rhinorrhea</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> and (rarely) <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> have been reported which may represent <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>.
</p>
<p>Published literature contains isolated reports of serious adverse reactions following the administration of PEG-electrolyte solution products in patients over 60 years of age. These adverse events include upper GI <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> from Mallory-Weiss Tear, <span class="product-label-link" type="condition" conceptid="22955" conceptname="Perforation of esophagus">esophageal perforation</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">asystole</span>, sudden <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span> with <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>, and â€œbutterfly-likeâ€? infiltrates on chest X-ray after <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and aspirating PEG.
</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="s19"></a><a name="section-7"></a><p></p>
<h1>7 DRUG INTERACTIONS
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s20"></a><a name="section-7.1"></a><p></p>
<h2>7.1 Drugs that May Lead to Fluid and Electrolyte Abnormalities
</h2>
<p class="First">Use caution when prescribing NuLYTELY for patients who are using medications that increase the risk for fluid and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte disturbances</span> or may increase the risk of adverse events of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, and prolonged QT in the setting of fluid and electrolyte abnormalities. Consider additional patient evaluations as appropriate [<span class="Italics">see Warnings and Precautions (<a href="#s10">5.1</a>, <a href="#s11">5.2</a>, <a href="#s12">5.3</a>, and <a href="#s13">5.4</a>)</span>] in patients taking these concomitant medications.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s21"></a><a name="section-7.2"></a><p></p>
<h2>7.2 Potential for Altered Drug Absorption
</h2>
<p class="First">Oral medication administered within one hour of the start of administration of NuLYTELY may be <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> from the gastrointestinal tract and the medication may not be absorbed properly.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s22"></a><a name="section-7.3"></a><p></p>
<h2>7.3 Stimulant Laxatives
</h2>
<p class="First">Concurrent use of stimulant laxatives and NuLYTELY may increase the risk of <span class="product-label-link" type="condition" conceptid="442121" conceptname="Mucosal ulcer">mucosal ulceration</span> or <span class="product-label-link" type="condition" conceptid="4148299" conceptname="Ischemic colitis">ischemic colitis</span>. Avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking NuLYTELY.
</p>
</div>
</div>
<div class="Section" data-sectionCode="43684-0">
<a name="s23"></a><a name="section-8"></a><p></p>
<h1>8 USE IN SPECIFIC POPULATIONS
</h1>
<div class="Section" data-sectionCode="42228-7">
<a name="s24"></a><a name="section-8.1"></a><p></p>
<h2>8.1 Pregnancy
</h2>
<p class="First">Pregnancy Category C.
</p>
<p>Animal reproduction studies have not been conducted with NuLYTELY. It is also not known whether NuLYTELY can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. NuLYTELY should be given to a pregnant woman only if clearly needed.
</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s25"></a><a name="section-8.2"></a><p></p>
<h2>8.3 Nursing Mothers
</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when NuLYTELY is administered to a nursing woman.
</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s26"></a><a name="section-8.3"></a><p></p>
<h2>8.4 Pediatric Use
</h2>
<p class="First">Safety and effectiveness of NuLYTELY in pediatric patients aged 6 months and older is supported by evidence from adequate and well-controlled clinical trials of NuLYTELY in adults with additional safety and efficacy data from published studies of similar formulations. Use of NuLYTELY in children younger than 2 years of age should be carefully monitored for occurrence of possible <span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>, as this solution has no caloric substrate. <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span> has been reported in one child and <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> has been reported in 3 children.
</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="s27"></a><a name="section-8.4"></a><p></p>
<h2>8.5 Geriatric Use
</h2>
<p class="First">Clinical studies of NuLYTELY did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s28"></a><a name="section-9"></a><p></p>
<h1>11 DESCRIPTION
</h1>
<p class="First">For oral solution: Each 4 liter (4L) NuLYTELY jug contains a white powder for reconstitution. NuLYTELY is a combination of polyethylene glycol 3350, an osmotic laxative, and electrolytes (sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride) for oral solution.
</p>
<p>Each 4 liter jug contains: polyethylene glycol 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.4 g. The solution is clear and colorless when reconstituted to a final volume of 4 liters with water.
</p>
<p>Polyethylene Glycol 3350, NF
</p>
<div class="Figure">
<a name="f01"></a><img alt="Polyethylene Glycol 3350 Structural Formula
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0003-01.jpg">
</div>
<p>Sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span>, USP
</p>
<p>The chemical name is NaHCO<span class="Sub">3</span>. The average Molecular Weight is 84.01. The structural formula is:
</p>
<div class="Figure">
<a name="f02"></a><img alt="Sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span> Structural Formula
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0003-02.jpg">
</div>
<p>Sodium Chloride, USP
</p>
<p>The chemical name is NaCl. The average Molecular Weight: 58.44. The structural formula is:
</p>
<p>Na<span class="Sup">+</span> Cl<span class="Sup">-</span></p>
<p>Potassium Chloride, USP
</p>
<p>The chemical name is KCl. The average Molecular Weight: 74.55. The structural formula is:
</p>
<p>K-Cl
</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s29"></a><a name="section-10"></a><p></p>
<h1>12 CLINICAL PHARMACOLOGY
</h1>
<div class="Section" data-sectionCode="43679-0">
<a name="s30"></a><a name="section-10.1"></a><p></p>
<h2>12.1 Mechanism of Action
</h2>
<p class="First">The primary mode of action is thought to be through the osmotic effect of polyethylene glycol 3350 which causes water to be retained in the colon and produces a watery stool.
</p>
</div>
<div class="Section" data-sectionCode="43681-6">
<a name="s31"></a><a name="section-10.2"></a><p></p>
<h2>12.2 Pharmacodynamics
</h2>
<p class="First">NuLYTELY induces as <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> which rapidly cleanses the bowel, usually within four hours.
</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="s32"></a><a name="section-10.3"></a><p></p>
<h2>12.3 Pharmacokinetics
</h2>
<p class="First">The pharmacokinetics of PEG3350 following administration of NuLYTELY were not assessed. Available pharmacokinetic information for oral PEG3350 suggests that it is poorly absorbed.
</p>
</div>
</div>
<div class="Section" data-sectionCode="43680-8">
<a name="s33"></a><a name="section-11"></a><p></p>
<h1>13 NONCLINICAL TOXICOLOGY
</h1>
<div class="Section" data-sectionCode="34083-6">
<a name="s34"></a><a name="section-11.1"></a><p></p>
<h2>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</h2>
<p class="First">Long term studies in animals have not been performed to evaluate carcinogenic potential of NuLYTELY. Studies to evaluate the possible impairment of fertility or mutagenic potential of NuLYTELY have not been performed.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s35"></a><a name="section-12"></a><p></p>
<h1>16 HOW SUPPLIED/STORAGE AND HANDLING
</h1>
<p class="First">In powdered form, for oral administration as a solution following reconstitution.
</p>
<p>NuLYTELY is available in a disposable jug in powdered form containing:
</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s36"></a><a name="section-12.1"></a><p></p>
<p class="First"><span class="Bold">NuLYTELY with Flavor Packs:</span> polyethylene glycol 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.48 g and flavoring ingredients 2.0 g (optional). When made up to 4 liters volume with water, the solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 17 mmol/L and potassium 5 mmol/L. Each jug has an attached package containing 4 flavor packs (optional); one each 2.0 g: Cherry, Lemon-Lime, Orange and Pineapple flavoring, in powdered form, for the addition of ONE pack by the pharmacist prior to dispensing.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s37"></a><a name="section-12.2"></a><p></p>
<p class="First"><span class="Bold">Lemon-Lime Flavor NuLYTELY:</span> polyethylene glycol 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.48 g and flavoring ingredients 2.0 g. When made up to 4 liters volume with water, the solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 17 mmol/L and potassium 5 mmol/L.
</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="s38"></a><a name="section-12.3"></a><p></p>
<p class="First"><span class="Bold">Storage:</span></p>
<p>Store at 25Â°C (77Â°F); excursions permitted to 15-30Â°C (59-86Â°F) [see USP Controlled Room Temperature]. When reconstituted, keep solution refrigerated. Use within 48 hours. Discard unused portion.
</p>
<p>Keep out of reach of children.
</p>
<p>NuLYTELY with Flavor PacksÂ  Â  Â  Â  Â  NDC 52268-400-01<br>Lemon-Lime Flavor NuLYTELYÂ  Â  Â  Â  NDC 52268-302-01
</p>
</div>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="s39"></a><a name="section-13"></a><p></p>
<h1>17 PATIENT COUNSELING INFORMATION
</h1>
<p class="First">See FDA-Approved Patient Labeling (<a href="#s40">Medication Guide</a>). Instruct patients:
</p>
<ul class="Disc">
<li>To let you know if they have trouble swallowing or are prone to <span class="product-label-link" type="condition" conceptid="4301596" conceptname="Regurgitation">regurgitation</span> or <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span>.
</li>
<li>Not to take other laxatives while they are taking NuLYTELY.
</li>
<li>To consume water or clear liquids during the bowel preparation and after completion of the bowel preparation up until 2 hours before the time of the colonoscopy.
</li>
<li>That if they experience severe <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> or <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, the administration of the solution should be slowed or temporarily discontinued until the symptoms abate. Advise patients to report these events to their health care provider.
</li>
<li>That if they have <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">hives</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rashes</span>, or any <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span>, they should discontinue the medication and contact their health care provider. Medication should be discontinued until they speak to their physician.
</li>
<li>To contact their healthcare provider if they develop signs and symptoms of <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>. <span class="Italics">[see Warnings and Precautions (<a href="#s10">5.1</a>)]</span>.
</li>
<li>That oral medication administered within one hour of the start of administration of NuLYTELY solution may be <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> from the GI tract and the medication may not be absorbed completely.
</li>
</ul>
<p>Distributed by Braintree Laboratories, Inc. Braintree, MA 02185
</p>
</div>
<div class="Section" data-sectionCode="42231-1">
<a name="s40"></a><a name="section-14"></a><p></p>
<p class="First"><span class="Bold">Medication Guide</span></p>
<p><span class="Bold">NuLYTELY<span class="Sup">Â®</span> (Noo-lite-ly)</span></p>
<p>(PEG-3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride oral solution)
</p>
<p>Read this Medication Guide before you start taking NuLYTELY. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.
</p>
<p><a name="p02"></a><span class="Bold">What is the most important information I should know about NuLYTELY?</span></p>
<p><span class="Bold">NuLYTELY and other osmotic bowel preparations can cause serious side effects, including:</span></p>
<p><span class="Bold">Serious loss of body fluid (<span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>) and changes in blood salts (electrolytes) in your blood.</span></p>
<p><span class="Bold">These changes can cause:</span></p>
<ul class="Disc">
<li><span class="Bold">abnormal heartbeats that can cause <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span></span></li>
<li>
<span class="Bold"><span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>.</span> This can happen even if you have never had a <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>.
</li>
<li><span class="Bold">kidney problems</span></li>
</ul>
<p><span class="Bold">Your chance of having <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">fluid loss</span> and changes in body salts with NuLYTELY is higher if you:</span></p>
<ul class="Disc">
<li>have heart problems
</li>
<li>have kidney problems
</li>
<li>take water pills or non-steroidal anti-inflammatory drugs (NSAIDS)
</li>
</ul>
<p><span class="Bold">Tell your healthcare provider right away if you have any of these symptoms of a loss of too much body fluid (<span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>) while taking NuLYTELY:</span></p>
<ul class="Disc">
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> that prevents you from keeping down the solution
</li>
<li><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>
</li>
<li>urinating less often than normal
</li>
<li><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>
</li>
</ul>
<p><span class="Bold">See Section â€œ<a href="#p01">What are the possible side effects of NuLYTELY</a>â€? for more information about side effects.</span></p>
<p><span class="Bold">What is NuLYTELY?</span></p>
<p>NuLYTELY is a prescription medicine used by adults to clean the colon before a colonoscopy. NuLYTELY cleans your colon by causing you to have <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>. Cleaning your colon helps your healthcare provider see the inside of your colon more clearly during your colonoscopy.
</p>
<p>NuLYTELY is safe and effective for use in pediatric patients aged 6 months and older.
</p>
<p><span class="Bold">Who should not take NuLYTELY?</span></p>
<p>Do not take NuLYTELY if your heathcare provider has told you that you have:
</p>
<ul class="Disc">
<li>a blockage in your bowel (obstruction)
</li>
<li>an opening in the wall of your stomach or intestine (<span class="product-label-link" type="condition" conceptid="193242" conceptname="Perforation of intestine">bowel perforation</span>)
</li>
<li>problems with food and fluid emptying from your stomach (gastric retention)
</li>
<li>a very dilated intestine (bowel)
</li>
<li>an <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> to any of the ingredients in NuLYTELY. See the end of this leaflet for a complete list of ingredients in NuLYTELY.
</li>
</ul>
<p><span class="Bold">What should I tell my healthcare provider before taking NuLYTELY?</span></p>
<p><span class="Bold">Before you take NuLYTELY, tell your healthcare provider if you:</span></p>
<ul class="Disc">
<li>have heart problems
</li>
<li>have stomach or bowel problems
</li>
<li>have <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>
</li>
<li>have problems with swallowing or gastric reflux
</li>
<li>have a history of <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>
</li>
<li>are withdrawing from drinking alcohol
</li>
<li>have a low blood salt (sodium) level
</li>
<li>have kidney problems
</li>
<li>any other medical conditions
</li>
<li>are pregnant. It is not known if NuLYTELY will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant.
</li>
<li>are breastfeeding or plan to breastfeed. It is not known if NuLYTELY passes into your breast milk. You and your healthcare provider should decide if you will take NuLYTELY while breastfeeding.
</li>
</ul>
<p><span class="Bold">Tell your healthcare provider about all the medicines you take,</span> including prescription and non-prescription medicines, vitamins, and herbal supplements.
</p>
<p>NuLYTELY may affect how other medicines work. Medicines taken by mouth may not be absorbed properly when taken within 1 hour before the start of NuLYTELY.
</p>
<p><span class="Bold">Especially tell your healthcare provider if you take:</span></p>
<ul class="Disc">
<li>medicines for blood pressure or heart problems
</li>
<li>medicines for kidney problems
</li>
<li>medicines for <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>
</li>
<li>water pills (diuretics)
</li>
<li>non-steroidal anti-inflammatory medicines (NSAID) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> medicines
</li>
<li>laxatives
</li>
</ul>
<p>Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure if you are taking any of the medicines listed above.
</p>
<p>Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
</p>
<p><span class="Bold">How should I take NuLYTELY?</span></p>
<p><span class="Bold">You must read, understand, and follow these instructions to take NuLYTELY the right way.</span></p>
<ul class="Disc">
<li>Take NuLYTELY exactly as your healthcare provider tells you to take it.
</li>
<li>Drink 240 mL (8 oz.) every 10 minutes. Rapid drinking of each portion is better than drinking small amounts.
</li>
<li>The first bowel movement should occur approximately one hour after you start drinking the solution.
</li>
<li>You may experience some <span class="product-label-link" type="condition" conceptid="4023572" conceptname="Abdominal bloating">abdominal bloating</span> and <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> before the bowels start to move. If severe <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> occur, stop drinking temporarily or drink each portion at longer intervals until the <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> goes away.
</li>
<li>Continue drinking until the watery stool is clear and free of solid matter. This usually requires 3 liters and it is best to drink all of the solution.
</li>
<li><span class="Bold">Do not take undissolved NuLYTELY powder that has not been mixed with water (diluted), it may increase your risk of <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">fluid loss</span> (<span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>).</span></li>
<li>Each jug of NuLYTELY must be reconstituted with water (diluted) to 4 liters total volume before drinking.
</li>
<li>Do not take other laxatives while taking NuLYTELY.
</li>
<li>
<span class="Bold">Do not eat solid foods on the day before your colonoscopy and until after your colonoscopy.</span> Drink only clear liquids:<ul class="Circle">
<li>the day before your colonoscopy
</li>
<li>while taking NuLYTELY
</li>
<li>after taking NuLYTELY until 2 hours before your colonoscopy
</li>
</ul>
</li>
</ul>
<p><a name="p01"></a><span class="Bold">What are the possible side effects of NuLYTELY?</span></p>
<p>NuLYTELY can cause serious side effects, including:
</p>
<ul class="Disc">
<li><span class="Bold">See Section â€œ<a href="#p02">What is the most important information I should know about NuLYTELY?</a>â€?</span></li>
<li>
<span class="Bold">changes in certain blood tests.</span> Your healthcare provider may do blood tests after you take NuLYTELY to check your blood for changes. Tell your healthcare provider if you have any symptoms of too much <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">fluid loss</span>, including:<ul class="Disc">
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>
</li>
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>
</li>
<li><span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>
</li>
<li><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>
</li>
<li>stomach (abdominal) cramping
</li>
<li><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>
</li>
<li>urinate less than usual
</li>
<li>trouble drinking clear liquid
</li>
<li><span class="Bold">heart problems. NuLYTELY may cause irregular heartbeats.</span></li>
<li><span class="Bold"><span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span></span></li>
<li>
<span class="Bold"><span class="product-label-link" type="condition" conceptid="4177703" conceptname="Ulcer">ulcers</span> of the bowel or bowel problems (<span class="product-label-link" type="condition" conceptid="4148299" conceptname="Ischemic colitis">ischemic colitis</span>).</span> Tell your healthcare provider right away if you have severe stomach-area (abdomen) <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> or <span class="product-label-link" type="condition" conceptid="197925" conceptname="Hemorrhage of rectum and anus">rectal bleeding</span>.
</li>
</ul>
</li>
</ul>
<p>The most common side effects of NuLYTELY include:
</p>
<ul class="Disc">
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>
</li>
<li>stomach (abdominal) fullness
</li>
<li><span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>
</li>
<li>stomach (abdominal) <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">cramps</span>
</li>
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>
</li>
<li>anal irritation
</li>
</ul>
<p>Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
</p>
<p>These are not all the possible side effects of NuLYTELY. For more information, ask your healthcare provider or pharmacist.
</p>
<p>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
</p>
<p><span class="Bold">How should I store NuLYTELY?</span></p>
<ul class="Disc"><li>Store NuLYTELY at room temperature, between 59Â°F to 86Â°F (15Â°C to 30Â°C).<br><span class="Bold">Keep NuLYTELY and all medicines out of the reach of children.</span>
</li></ul>
<p><span class="Bold">General information about the safe and effective use of NuLYTELY.</span></p>
<p>Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use NuLYTELY for a condition for which it was not prescribed. Do not give NuLYTELY to other people, even if they are going to have the same procedure you are. It may harm them.
</p>
<p>This Medication Guide summarizes important information about NuLYTELY. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information that is written for healthcare professionals.
</p>
<p>For more information, go to www.braintreelabs.com or call 1-800-874-6756.
</p>
<p><span class="Bold">What are the ingredients in NuLYTELY?</span></p>
<p><span class="Bold">Active ingredients:</span> polyethylene glycol 3350, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, sodium chloride, and potassium chloride.
</p>
<p><span class="Bold">Inactive ingredients:</span> cherry flavoring, lemon-lime flavoring, orange flavoring, pineapple flavoring (flavor only)
</p>
<p>Braintree Laboratories, Inc.
</p>
<p>Braintree, MA 02185, USA
</p>
<p>This Medication Guide has been approved by the U.S. Food and Drug Administration.
</p>
<p>Revised 9/2013
</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s41"></a><a name="section-15"></a><p></p>
<p class="First">Principal Display Panel
</p>
<p>FILL TO THE TOP OF THE LINE ON BOTTLE
</p>
<p>NDC 52268-400-01
</p>
<p>TO PHARMACIST AND PATIENT:<br>Mixing information is on base<br>label. Discard unused flavor packs. Package insert may be<br>removed before dispensing. Dispense the enclosed Medication Guide to each patient.
</p>
<p><span class="Bold">NuLYTELY</span><span class="Bold"><span class="Sup">Â®</span></span></p>
<p><span class="Bold">PEG-3350, Sodium Chloride,<br>Sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span><br>and Potassium Chloride<br>for Oral Solution</span></p>
<p><span class="Bold">With Flavor Packs</span></p>
<p>When reconstituted with water to a volume of 4 liters, this solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 17 mmol/L and potassium 5 mmol/L
</p>
<p>Each disposable jug contains, in powdered form: polyethylene glycol 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.48 g, flavor ingredients 2.0 g.
</p>
<p><span class="Bold">RX ONLY</span></p>
<p><span class="Bold">Braintree</span></p>
<p><span class="Bold">Laboratories, Inc</span></p>
<p><span class="Bold">Braintree, MA 02185</span>              Rev 09/13
</p>
<div class="Figure">
<a name="f03"></a><img alt="Principal Display Panel
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0003-03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s42"></a><a name="section-16"></a><p></p>
<p class="First"><span class="Bold">Principal Display Panel â€“ Cherry Flavor Pack</span></p>
<p><span class="Bold">Cherry</span></p>
<p><span class="Bold">NuLYTELY<span class="Sup">Â®</span></span></p>
<p><span class="Bold">Flavor Pack</span></p>
<p>FOR USE ONLY WITH 4L NuLYTELY<span class="Sup">Â®</span><br>PEG-3350, Sodium Chloride, Sodium Bocarbonate<br>and Potassium Chloride for Oral Solution
</p>
<p><span class="Bold">Net Wt. 2.0 g S-C 8/07</span></p>
<div class="Figure">
<a name="f04"></a><img alt="Principal Display Panel â€“ Cherry Flavor Pack
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0004-04.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s43"></a><a name="section-17"></a><p></p>
<p class="First"><span class="Bold">Principal Display Panel â€“ Orange Flavor Pack</span></p>
<p><span class="Bold">Orange</span></p>
<p><span class="Bold">NuLYTELY<span class="Sup">Â®</span></span></p>
<p><span class="Bold">Flavor Pack</span></p>
<p>FOR USE ONLY WITH 4L NuLYTELY<span class="Sup">Â®</span><br>PEG-3350, Sodium Chloride, Sodium Bocarbonate<br>and Potassium Chloride for Oral Solution
</p>
<p><span class="Bold">Net Wt. 2.0 g S-O 8/07</span></p>
<div class="Figure">
<a name="f05"></a><img alt="Principal Display Panel â€“ Orange Flavor Pack
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0004-05.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s44"></a><a name="section-18"></a><p></p>
<p class="First"><span class="Bold">Principal Display Panel â€“ Pineapple Flavor Pack</span></p>
<p><span class="Bold">Pineapple</span></p>
<p><span class="Bold">NuLYTELY<span class="Sup">Â®</span></span></p>
<p><span class="Bold">Flavor Pack</span></p>
<p>FOR USE ONLY WITH 4L NuLYTELY<span class="Sup">Â®</span><br>PEG-3350, Sodium Chloride, Sodium Bocarbonate<br>and Potassium Chloride for Oral Solution
</p>
<p><span class="Bold">Net Wt. 2.0 g S-P 8/07</span></p>
<div class="Figure">
<a name="f06"></a><img alt="Principal Display Panel â€“ Pineapple Flavor Pack
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0004-06.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s45"></a><a name="section-19"></a><p></p>
<p class="First"><span class="Bold">Principal Display Panel â€“ Lemon-Lime Flavor Pack</span></p>
<p><span class="Bold">Lemon-Lime</span></p>
<p><span class="Bold">NuLYTELY<span class="Sup">Â®</span></span></p>
<p><span class="Bold">Flavor Pack</span></p>
<p>FOR USE ONLY WITH 4L NuLYTELY<span class="Sup">Â®</span><br>PEG-3350, Sodium Chloride, Sodium Bocarbonate<br>and Potassium Chloride for Oral Solution
</p>
<p><span class="Bold">Net Wt. 2.0 g S-L 8/07</span></p>
<div class="Figure">
<a name="f07"></a><img alt="Principal Display Panel â€“ Lemon-Lime Flavor Pack
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=95586bca-c969-4097-aba6-98f308469e7a&amp;name=nul00-0004-07.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NULYTELY WITH FLAVOR PACKSÂ 		
					</strong><br><span class="contentTableReg">polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:52268-400</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:52268-400-01</td>
<td class="formItem">1  in 1 KIT</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">PartÂ #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 BOTTLE </td>
<td class="formItem">4Â L</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 PACKET </td>
<td class="formItem">0.0002Â L</td>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 3</strong></td>
<td class="formItem">1 PACKET </td>
<td class="formItem">0.0002Â L</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 4</strong></td>
<td class="formItem">1 PACKET </td>
<td class="formItem">0.0002Â L</td>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 5</strong></td>
<td class="formItem">1 PACKET </td>
<td class="formItem">0.0002Â L</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 5</td></tr>
<tr><td class="contentTableTitle">
<strong>NULYTELYÂ 		
					</strong><br><span class="contentTableReg">polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Polyethylene Glycol 3350</strong> (Polyethylene Glycol 3350) </td>
<td class="formItem">Polyethylene Glycol 3350</td>
<td class="formItem">420Â g Â inÂ 4Â L</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span></strong> (Sodium Cation and <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span> Ion) </td>
<td class="formItem">Sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">Bicarbonate</span></td>
<td class="formItem">5.72Â g Â inÂ 4Â L</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Sodium Chloride</strong> (Sodium Cation and Chloride Ion) </td>
<td class="formItem">Sodium Chloride</td>
<td class="formItem">11.2Â g Â inÂ 4Â L</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Potassium Chloride</strong> (Potassium Cation and Chloride Ion) </td>
<td class="formItem">Potassium Chloride</td>
<td class="formItem">1.48Â g Â inÂ 4Â L</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">4 L in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 5</td></tr>
<tr><td class="contentTableTitle">
<strong>FLAVOR PACKÂ 		
					</strong><br><span class="contentTableReg">flavor pack powder</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Cherry</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">0.0002 L in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 3 of 5</td></tr>
<tr><td class="contentTableTitle">
<strong>FLAVOR PACKÂ 		
					</strong><br><span class="contentTableReg">flavor pack powder</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Orange</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">0.0002 L in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 4 of 5</td></tr>
<tr><td class="contentTableTitle">
<strong>FLAVOR PACKÂ 		
					</strong><br><span class="contentTableReg">flavor pack powder</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Pineapple</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">0.0002 L in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 5 of 5</td></tr>
<tr><td class="contentTableTitle">
<strong>FLAVOR PACKÂ 		
					</strong><br><span class="contentTableReg">flavor pack powder</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Lemon</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Lime (Citrus)</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">0.0002 L in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019797</td>
<td class="formItem">04/17/2007</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Braintree Laboratories, Inc.
							(107904591)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Braintree Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">617357954</td>
<td class="formItem">MANUFACTURE(52268-400), ANALYSIS(52268-400), LABEL(52268-400), PACK(52268-400)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>f5c1fa80-77d3-445f-a748-663a86cee202</div>
<div>Set id: 95586bca-c969-4097-aba6-98f308469e7a</div>
<div>Version: 3</div>
<div>Effective Time: 20130930</div>
</div>
</div>Â <div class="DistributorName">Braintree Laboratories, Inc.</div></p>
</body></html>
